These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6861440)

  • 1. Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
    Ferrari C; Barbieri C; Caldara R; Rampini P; Paracchi A; Boghen M; Rauhe WG
    Clin Pharmacol Ther; 1983 Jul; 34(1):74-8. PubMed ID: 6861440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary evaluation of the effect of ibopamine on the secretion of prolactin].
    Scarazzati E; Catenazzo G; Melloni CF; Ghirardi P; Bianco L
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1631-5. PubMed ID: 6667307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
    Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
    Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.
    Rolandi E; Marchetti G; Franceschini R; Cicchetti V; Gianrossi R; Cantoni V; Barreca T
    Eur J Clin Pharmacol; 1986; 29(5):629-30. PubMed ID: 3956568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man.
    Masturzo P; De Maria A; Murialdo G; Bonura ML; Zauli C; Polleri A
    J Clin Endocrinol Metab; 1985 Aug; 61(2):378-81. PubMed ID: 4008612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients.
    Ferrari C; Paracchi A; Romano C; Gerevini G; Boghen M; Barreca A; Fortini P; Dubini A
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):467-76. PubMed ID: 2908102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the orally absorbed dopamine analogue N-methyldopamine diisobutyric ester on plasma prolactin levels.
    Lombardi G; Tommaselli A; Fariello C; Quattrone A; Annunziato L
    Eur J Clin Pharmacol; 1983; 25(1):131-3. PubMed ID: 6617716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.
    Ferrari C; Romussi M; Benco R; Rampini P; Mailland F
    Acta Endocrinol (Copenh); 1983 May; 103(1):1-6. PubMed ID: 6407250
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
    Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
    J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.
    Goldman JA; Molitch ME; Thorner MO; Vale W; Rivier J; Reichlin S
    J Endocrinol Invest; 1987 Aug; 10(4):397-406. PubMed ID: 3119697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and prolactin secretion in acromegaly: correlations between hormonal dynamics and immunocytochemical findings.
    Bassetti M; Arosio M; Spada A; Brina M; Bazzoni N; Faglia G; Giannattasio G
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1195-204. PubMed ID: 3142915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients.
    Verde G; Oppizzi G; Colussi G; Cremascoli G; Botalla L; Müller EE; Silvestrini F; Chiodini PG; Liuzzi A
    Clin Endocrinol (Oxf); 1976 Jul; 5(4):419-23. PubMed ID: 971548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pyridoxine on human hypophyseal trophic hormone release: a possible stimulation of hypothalamic dopaminergic pathway.
    Delitala G; Masala A; Alagna S; Devilla L
    J Clin Endocrinol Metab; 1976 Mar; 42(3):603-6. PubMed ID: 1254699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibopamine-induced reduction of serum prolactin level and milk secretion in puerperal women.
    Nappi C; Colace G; Affinito P; Taglialatela M; Di Renzo GF; Montemagno U; Annunziato L
    Eur J Clin Pharmacol; 1990; 39(2):133-5. PubMed ID: 2253662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.